Antiviral compound fully protects monkeys from Ebola

Rhesus monkeys were completely protected from the deadly Ebola virus when treated three days after infection with a compound that blocks the virus's ability to replicate. These encouraging preclinical results suggest the compound, known as GS-5734, should be further developed as a potential treatment, according to research findings to be presented tomorrow at the IDWeek conference. Travis Warren, Ph.D., a principal investigator at the U.S. Army Medical Research Institute of Infectious Disease...
More